What Is Pharmacogenomics? The convergence of the life sciences, information technology, high-speed computation and genomics has created a unique industry that may well be among the most attractive investment opportunity for investors today. By Udayan Gupta September 13, 2010
This content is from: Portfolio The FDA’s Pulse Quickens After years of complaints that it was too protectionist, the Food and Drug Administration seems to have entered an era of faster approvals. By Fran Hawthorne August 01, 2012
